Matt Devalaraja

Co-CSO, Head-Research & Development at Corvidia Therapeutics, Inc.

Matt Devalaraja

Matt Devalaraja

Co-CSO, Head-Research & Development at Corvidia Therapeutics, Inc.

Overview
RelSci Relationships

4355

Relationships
RelSci Relationships are individuals Matt Devalaraja likely has professional access to. A relationship does not necessarily indicate a personal connection.

President & General Manager at Pfizer Vaccines LLC

Relationship likelihood: Strong

Chief Executive Officer at Pandion Therapeutics, Inc.

Relationship likelihood: Strong

Chairman of the Board & Chief Executive Officer at Pfizer, Inc.

Relationship likelihood: Strong

Assistant General Counsel & Assistant Secretary in the Corporate Governance Group, Legal Division at Pfizer, Inc.

Relationship likelihood: Strong

Chief Scientific Officer & President, Worldwide Research, Development & Medical at Pfizer, Inc.

Relationship likelihood: Strong

Chief Corporate Affairs Officer & Executive Vice President at Pfizer, Inc.

Relationship likelihood: Strong

Chief Scientific Officer at Samumed LLC

Relationship likelihood: Strong

Senior Director, Worldwide Safety & Regulatory at Pfizer, Inc.

Relationship likelihood: Strong

President, Treasurer & Director at Array BioPharma Inc.

Relationship likelihood: Strong

Director & Treasurer at Atlantic District - Lutheran Church Missouri Synod

Relationship likelihood: Strong

Paths to Matt Devalaraja
Potential Connections via
Relationship Science
You
Matt Devalaraja
Co-CSO, Head-Research & Development at Corvidia Therapeutics, Inc.
Education
PhD Unknown

The University of Kentucky is a public, land grant university dedicated to improving people's lives through excellence in education, research and creative work, service, and health care. As Kentucky's flagship institution, the University plays a critical leadership role by promoting diversity, inclusion, economic development, and human well-being. The University of Kentucky is guided by its core values: Integrity, Excellence, Mutual respect and human dignity, Diversity and inclusion, Academic freedom, Personal and institutional responsibility and accountability, Shared governance, A sense of community, Work-life sensitivity, Civic engagement and Social responsibility.

Career History
Co-CSO, Head-Research & Development
2015 - Current

Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA.

Head of Biologics Discovery, Ann Arbor
Tenure Unconfirmed

Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Head of Immunology Research, Pharmacokinetics & Toxicology Groups
Tenure Unconfirmed

Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD.

Investments
Details Hidden

Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA.

Other Affiliations
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Matt Devalaraja. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Matt Devalaraja's profile does not indicate a business or promotional relationship of any kind between RelSci and Matt Devalaraja.